Synchronoss Anuncia Encerramento da Oferta de Ações Ordinárias e Notas Seniores no valor de US$235 milhões

A Synchronoss também arrecadou US$75 milhões por meio de uma colocação privada de ações preferenciais Produto líquido usado para refinanciar a estrutura de capital da empresa BRIDGEWATER, N.J., July 07, 2021 (GLOBE NEWSWIRE) — A Synchronoss Technologies, Inc. (NASDAQ: SNCR), líder global e inovadora de soluções de nuvem, mensagens e digitais, anunciou hoje o encerramento no […]

Read More »

Synchronoss annonce la clôture de 235 millions de dollars d’offres d’actions ordinaires et de billets de premier rang

En outre, Synchronoss a levé 75 millions de dollars par le biais d’un placement privé d’actions privilégiées Produit net utilisé pour refinancer la structure du capital de la société BRIDGEWATER, New Jersey, 07 juill. 2021 (GLOBE NEWSWIRE) — Synchronoss Technologies, Inc. (NASDAQ : SNCR), un leader et innovateur mondial en solutions de cloud, de messagerie et de numérique, […]

Read More »

GES Appoints New Management Positions for Event Intelligence in Europe and the Middle East

Daryl Burgess will lead the Customer Support team for the UK, and Ali Shah for the Middle East COVENTRY, United Kingdom, July 7, 2021 /PRNewswire/ — GES has expanded their client service team for their Event Intelligence business and appointed Daryl Burgess and Ali Shah to Customer Support Managers for the UK and Middle East, respectively. […]

Read More »

‘Falcon’s Beyond Global’ Launches as Fully Integrated Development Enterprise for IP-Driven Parks, Resorts, Media, & Merchandise

Falcon’s Beyond Global New enterprise brings proprietary ‘Katmandu’ and partner IPs to global markets through theme parks, resorts, feature films, episodic series, consumer products, and beyond. Joint venture with Meliá Hotels International brings access to prime real estate and a global operating presence in major tourist destinations in 40 countries. ORLANDO Fla., July 07, 2021 […]

Read More »

GT Biopharma Announces Sponsored Research Agreement With Dr. Jeffrey S. Miller Of The University Of Minnesota

Deepening relationship between GT Biopharma and Dr. Jeffrey Miller TriKE™ improves FT538 iPSC NK cells from Fate Therapeutics in prostate cancer model GTB-3550 continues to demonstrate clinical success without significant toxicities BEVERLY HILLS, Calif., July 7, 2021 /PRNewswire/ — GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on […]

Read More »

ISW Holdings Closes on Its 1st phase of over 100MW Georgia Crypto Mining Farm Capable of Driving Over $100M in Annual Gross Revs

LAS VEGAS, July 07, 2021 (GLOBE NEWSWIRE) — via InvestorWire — ISW Holdings, Inc. (OTC: ISWH) (“ISW Holdings” or the “Company”), a global brand management holdings company, is excited to announce that it has finalized its land lease development agreement, which grants the Company full use of a 1st phase 7-acre parcel of property in […]

Read More »